Search Results - "Bijole, Phyllis"
-
1
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs
Published in Clinical infectious diseases (23-10-2020)“…Abstract Background People who inject drugs have a high prevalence of hepatitis C virus (HCV) and significant disease associated with drug use; however, HCV…”
Get full text
Journal Article -
2
Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine
Published in Addiction (Abingdon, England) (01-11-2024)“…Background/Aims In people with opioid use disorder (OUD), buprenorphine is a vital treatment to decrease opioid use and overdose. The US Food and Drug…”
Get full text
Journal Article -
3
Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32mg/day of buprenorphine
Published in Addiction (Abingdon, England) (01-11-2024)“…Background/AimsIn people with opioid use disorder (OUD), buprenorphine is a vital treatment to decrease opioid use and overdose. The US Food and Drug…”
Get full text
Journal Article -
4
“I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons
Published in Health services research (01-08-2023)“…Objective To explore barriers to care continuity among formerly incarcerated persons with HIV and/or hepatitis C. Data Sources and Study Setting We draw on…”
Get full text
Journal Article -
5
Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use
Published in The International journal of drug policy (01-01-2023)“…•Hepatitis C cure improves quality of life for opioid use disorder patients.•Medications for opioid use disorder improve quality of life during…”
Get full text
Journal Article -
6
High Rates of High-Risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth
Published in Open forum infectious diseases (12-11-2024)Get full text
Journal Article -
7
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment
Published in Journal of addiction medicine (01-01-2022)“…The ANCHOR program offered buprenorphine treatment to people who inject drugs engaged in hepatitis C (HCV) treatment at a Washington, DC harm reduction…”
Get full text
Journal Article -
8
Initiation of Low-Threshold Buprenorphine in Non-Treatment Seeking Patients with Opioid Use Disorder Engaged in HCV Treatment
Published in Journal of addiction medicine (01-01-2022)Get full text
Journal Article -
9
799. Unstable Housing, Daily Drug Use, and Transactional Sex are Associated with Viremia in Transgender Individuals Living with HIV
Published in Open forum infectious diseases (15-12-2022)Get full text
Journal Article -
10
-
11
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment
Published in Journal of addiction medicine (05-02-2021)Get full text
Journal Article -
12
844. High Risk Behaviors, Suboptimal HIV Viral Suppression, and Limited PrEP Use among People Who Engage in Transactional Sex
Published in Open forum infectious diseases (04-12-2021)Get full text
Journal Article -
13
Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment
Published in Open forum infectious diseases (01-03-2022)“…Abstract Background Daily oral preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) prevents human immunodeficiency…”
Get full text
Journal Article -
14
PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV
Published in Open forum infectious diseases (01-10-2022)“…BackgroundIndividuals with hepatitis C (HCV) represent a population that may benefit from pre-exposure prophylaxis (PrEP), given the overlapping risk factors…”
Get full text
Journal Article -
15
859. Suboptimal Uptake, Retention, and Adherence of Daily Oral PrEP Among People with OUD Receiving HCV Treatment
Published in Open forum infectious diseases (04-12-2021)Get full text
Journal Article -
16
-
17
2900. High Rates of Experienced and Witnessed Opioid Overdose in PWID Receiving HCV Treatment: Data From the ANCHOR Study
Published in Open forum infectious diseases (23-10-2019)Get full text
Journal Article